Search Results 2301-2310 of 21334 for anti-TNF drugs

  1. Using AI to screen 30 million drug candidates against SARS-CoV-2 - Mayo Clinic News Network

    Mayo Clinic researchers and collaborators used computer simulation and artificial intelligence to virtually screen 30 million drug candidates that may block ...

  2. Oncology (Medical) - Overview - Mayo Clinic

    Targeted drug therapy; Biological therapy; Chemotherapy; Hormone therapy; Supportive and Palliative Care Therapies; Experimental therapies; Other systemic ...

  3. Overview - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    Sarkaria's lab studies methods to improve treatment for glioblastoma. Developing novel therapeutics for glioblastoma. Our lab is dedicated to improving outcomes ...

  4. Early Atherosclerosis Clinic in Minnesota - Overview

    Early diagnosis and treatment can stop atherosclerosis from worsening and prevent a heart attack, stroke or other medical emergency. Mayo Clinic uses early ...

  5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    By condition, treatment or drug name ... Prior therapy with interferon, talimogene laherparepvec (Imlygic®), IL-2 directed therapy, anti ... Note: An ...

  6. Methyldopa And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  7. Meningococcal Vaccine, Tetanus Toxoid Conjugate Quadrivalent (Intramuscular Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. MenQuadfi. Descriptions. Meningococcal, tetanus ...

  8. Sunscreen Agent (Topical Application Route) Before Using - Mayo Clinic

    Your doctor may also advise you to take vitamin D supplements. Check with your doctor about this. Drug Interactions. Although certain medicines should not be ...

  9. Inebilizumab-Cdon (Intravenous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Inebilizumab-Cdon ... It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. ... Drugs & Supplements ...

  10. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    Received any experimental drugs or anti-neoplastic therapy ≤ 4 weeks prior to receiving the first dose of study treatment;; Received a live vaccine ≤ 30 ...